CREDIT AGREEMENT amongCredit Agreement • March 29th, 2018 • pSivida Corp. • Laboratory analytical instruments
This CREDIT AGREEMENT (as may be amended, restated, supplemented, or otherwise modified from time to time, this “Agreement”) dated as of March 28, 2018 (the “Closing Date”), among PSIVIDA CORP., a Delaware corporation (“Borrower”), the financial institutions party hereto from time to time as lenders (each a “Lender” and collectively, the “Lenders”) and SWK FUNDING LLC (in its individual capacity, “SWK”), as Agent for all Lenders.
ContractRegistration Rights Agreement • March 29th, 2018 • pSivida Corp. • Laboratory analytical instruments • New York
This REGISTRATION RIGHTS AGREEMENT (as it may be amended from time to time in accordance with the terms hereof, the “Agreement”), dated as of March 28, 2018, is made by and among pSivida Corp., a Delaware corporation (the “Company”) and EW Healthcare Partners L.P. and EW Healthcare Partners-A L.P. (together with their Permitted Transferees that become party hereto, the “Investors”).
SECOND SECURITIES PURCHASE AGREEMENTSecond Securities Purchase Agreement • March 29th, 2018 • pSivida Corp. • Laboratory analytical instruments • New York
This Second Securities Purchase Agreement (this “Agreement”) is dated as of March 28, 2018, by and among pSivida Corp., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 29th, 2018 • pSivida Corp. • Laboratory analytical instruments • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of March 28, 2018, by and among pSivida Corp., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
